Jacobio Pharmaceuticals (JACOBIO-B) Executes HK$0.47 Million On-Market Share Buyback, Treasury Shares Rise to 6.98 Million

Bulletin Express05-12

Jacobio Pharmaceuticals Group Co., Ltd. repurchased 78,900 ordinary shares on 12 May 2026 through on-market transactions on the Hong Kong Stock Exchange, paying between HK$5.90 and HK$5.92 per share for a total consideration of HK$0.47 million (volume-weighted average price: HK$5.91).

Following the transaction, issued shares outstanding (excluding treasury shares) decreased by 0.010 % to 784.77 million, while treasury shares increased to 6.98 million. Total issued share capital remained unchanged at 791.76 million shares.

The buyback was conducted under the repurchase mandate granted on 10 June 2025, which authorises the company to repurchase up to 78.87 million shares. Cumulative repurchases under this mandate now stand at 3.96 million shares, equivalent to 0.50 % of the share count on the mandate date. In line with Hong Kong listing rules, Jacobio is subject to a moratorium on new share issues or treasury-share disposals until 11 June 2026.

All repurchased shares are being held as treasury shares; none have been cancelled. The company confirmed that the buyback complied with the Main Board Listing Rules and the terms of its previously filed explanatory statement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1113797881?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-12 21:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1113797881","market":"hk","top_or_hot":-1,"title":"Jacobio Pharmaceuticals (JACOBIO-B) Executes HK$0.47 Million On-Market Share Buyback, Treasury Shares Rise to 6.98 Million","media":"Bulletin Express","content":"<p>Jacobio Pharmaceuticals Group Co., Ltd. repurchased 78,900 ordinary shares on 12 May 2026 through on-market transactions on the Hong Kong Stock Exchange, paying between HK$5.90 and HK$5.92 per share for a total consideration of HK$0.47 million (volume-weighted average price: HK$5.91).</p>\n<p>Following the transaction, issued shares outstanding (excluding treasury shares) decreased by 0.010 % to 784.77 million, while treasury shares increased to 6.98 million. Total issued share capital remained unchanged at 791.76 million shares.</p>\n<p>The buyback was conducted under the repurchase mandate granted on 10 June 2025, which authorises the company to repurchase up to 78.87 million shares. Cumulative repurchases under this mandate now stand at 3.96 million shares, equivalent to 0.50 % of the share count on the mandate date. In line with Hong Kong listing rules, Jacobio is subject to a moratorium on new share issues or treasury-share disposals until 11 June 2026.</p>\n<p>All repurchased shares are being held as treasury shares; none have been cancelled. The company confirmed that the buyback complied with the Main Board Listing Rules and the terms of its previously filed explanatory statement.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jacobio Pharmaceuticals (JACOBIO-B) Executes HK$0.47 Million On-Market Share Buyback, Treasury Shares Rise to 6.98 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJacobio Pharmaceuticals (JACOBIO-B) Executes HK$0.47 Million On-Market Share Buyback, Treasury Shares Rise to 6.98 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-12 21:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Jacobio Pharmaceuticals Group Co., Ltd. repurchased 78,900 ordinary shares on 12 May 2026 through on-market transactions on the Hong Kong Stock Exchange, paying between HK$5.90 and HK$5.92 per share for a total consideration of HK$0.47 million (volume-weighted average price: HK$5.91).</p>\n<p>Following the transaction, issued shares outstanding (excluding treasury shares) decreased by 0.010 % to 784.77 million, while treasury shares increased to 6.98 million. Total issued share capital remained unchanged at 791.76 million shares.</p>\n<p>The buyback was conducted under the repurchase mandate granted on 10 June 2025, which authorises the company to repurchase up to 78.87 million shares. Cumulative repurchases under this mandate now stand at 3.96 million shares, equivalent to 0.50 % of the share count on the mandate date. In line with Hong Kong listing rules, Jacobio is subject to a moratorium on new share issues or treasury-share disposals until 11 June 2026.</p>\n<p>All repurchased shares are being held as treasury shares; none have been cancelled. The company confirmed that the buyback complied with the Main Board Listing Rules and the terms of its previously filed explanatory statement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01167","symbol_name":"加科思-B","start_time":0,"source_url":"","article_id":"1113797881","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1113797881","pubTimestamp":1778591011,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Jacobio Pharmaceuticals Group Co., Ltd. repurchased 78,900 ordinary shares on 12 May 2026 through on-market transactions on the Hong Kong Stock Exchange, paying between HK$5.90 and HK$5.92 per share...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01167":"加科思-B"},"translate_title":"雅可比奥制药（JACOBIO-B）执行47万港元场内股份回购，库存股升至698万股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01167":1},"content_text":"Jacobio Pharmaceuticals Group Co., Ltd. repurchased 78,900 ordinary shares on 12 May 2026 through on-market transactions on the Hong Kong Stock Exchange, paying between HK$5.90 and HK$5.92 per share for a total consideration of HK$0.47 million (volume-weighted average price: HK$5.91).\nFollowing the transaction, issued shares outstanding (excluding treasury shares) decreased by 0.010 % to 784.77 million, while treasury shares increased to 6.98 million. Total issued share capital remained unchanged at 791.76 million shares.\nThe buyback was conducted under the repurchase mandate granted on 10 June 2025, which authorises the company to repurchase up to 78.87 million shares. Cumulative repurchases under this mandate now stand at 3.96 million shares, equivalent to 0.50 % of the share count on the mandate date. In line with Hong Kong listing rules, Jacobio is subject to a moratorium on new share issues or treasury-share disposals until 11 June 2026.\nAll repurchased shares are being held as treasury shares; none have been cancelled. The company confirmed that the buyback complied with the Main Board Listing Rules and the terms of its previously filed explanatory statement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1113797881","isCrawlerRequest":true}